GLP-1 for Weight Loss and Diabetes
US$ 24.65
glp-1 half life Recent updates on agonists: Current advancements & challenges GLP-1s: The Second Serving -
Description
Using GLP-1 injections with lifestyle changes supports better outcomes
A 2025 study found that 40% of semaglutide users exhibited increased residual gastric content versus only 3% of non-users
Those are the strong points
Based on reported changes in diet and food spending among GLP-1 users, Roe (2025) attempts to quantify what this could mean for the food system
(2025) 17:e94926
